Untargeted Antifungal Treatment in Nonneutropenic Critically Ill Patients: Should Further Studies Be Performed Based on Trial Sequential Analysis Results?

Antimicrob Agents Chemother. 2018 Jun 26;62(7):e00810-18. doi: 10.1128/AAC.00810-18. Print 2018 Jul.

Authors

Andrea Cortegiani¹, Antonino Giarratano²

Affiliations

¹ Department of Biopathology and Medical Biotechnologies (DIBIMED), Section of Anesthesia Analgesia, Intensive Care, and Emergency, Policlinico Paolo Giaccone, University of Palermo, Palermo, Italy cortegiania@gmail.com.
² Department of Biopathology and Medical Biotechnologies (DIBIMED), Section of Anesthesia Analgesia, Intensive Care, and Emergency, Policlinico Paolo Giaccone, University of Palermo, Palermo, Italy.

No abstract available

Keywords: Candida spp.; antifungal drug; empirical treatment; prophylaxis; untargeted treatment.

Publication types

Letter
Comment

MeSH terms

Antifungal Agents*
Critical Illness
Economics, Pharmaceutical
Humans
Mycoses*
Network Meta-Analysis

Substances

Antifungal Agents